Marc Chadeau-Hyam

Oct 26, 2023 | flipboard.com | Jordan Bortz |Lucija Klaric |Peter Ward |Michael Geer |Marc Chadeau-Hyam |Dragana Vuckovic | +2 more

1 day agoThis is the sad truth. When scientists realized that nearly 10 billion snow crabs had gone missing from Bering Sea between 2018 to 2021, they weren’t sure where they could have gone. After searching for a potentially migrating population, however, they came to a much more unfortunate conclusion. A new …

Oct 26, 2023 | nature.com | Marc Chadeau-Hyam |Dragana Vuckovic |Jordan Bortz

AbstractBiological age captures physiological deterioration better than chronological age and is amenable to interventions. Blood-based biomarkers have been identified as suitable candidates for biological age estimation. This study aims to improve biological age estimation using machine learning models and a feature-set of 60 circulating biomarkers available from the UK Biobank (n = 306,116).

Oct 24, 2023 | nature.com | Christina J Atchison |Bethan Davies |Emily Cooper |Christl A. Donnelly |Marc Chadeau-Hyam |Graham Cooke | +1 more

AbstractThe COVID-19 pandemic is having a lasting impact on health and well-being. We compare current self-reported health, quality of life and symptom profiles for people with ongoing symptoms following COVID-19 to those who have never tested positive for SARS-CoV-2 infection and those who have recovered from COVID-19. Overall, 276,840/800,000 (34·6%) of invited participants took part.

Aug 16, 2023 | nature.com | Bethan Davies |Christina J Atchison |Wendy Barclay |Deborah Ashby |Ara Darzi |Graham Cooke | +3 more

AbstractThe value of SARS-CoV-2 lateral flow immunoassay (LFIA) tests for estimating individual disease risk is unclear. The REACT-2 study in England, UK, obtained self-administered SARS-CoV-2 LFIA test results from 361,801 adults in January-May 2021. Here, we link to routine data on subsequent hospitalisation (to September 2021), and death (to December 2021).

Jun 19, 2023 | adc.bmj.com | Christina J Atchison |Matthew Whitaker |Christl A. Donnelly |Marc Chadeau-Hyam

Data analysisWe estimated the prevalence of persistent symptoms at 3 months postsymptom onset in individuals with a history of COVID-19. We included all self-reported prior COVID-19 episodes including test confirmed and suspected but not confirmed. We only included those who reported onset of COVID-19 ≥3 months prior to the date of the survey and for whom we had complete data.